Home » PNB Genetics News & Research » Genetic testing in the epilepsies—developments and dilemmas

Genetic testing in the epilepsies—developments and dilemmas

By: Annapurna Poduri, Beth Rosen Sheidley, Sara Shostak, and Ruth Ottman
April 15, 2014
Nature Reviews: Neurology 10:4

Abstract In the past two decades, the number of genes recognized to have a role in the epilepsies has dramatically increased. The availability of testing for epilepsy-related genes is potentially helpful for clarification of the diagnosis and prognosis, selection of optimal treatments, and provision of information for family planning. For some patients, identification of a specific genetic cause of their epilepsy has important personal value, even in the absence of clear clinical utility. The availability of genetic testing also raises new issues that have only begun to be considered. These issues include the growing importance of educating physicians about when and how to test patients, the need to ensure that affected individuals and their families can make informed choices about testing and receive support after receiving the results, and the question of what the positive and negative consequences of genetic testing will be for affected individuals, their family members, and society.

Click here for full text